EDGAR Filing Documents for 0001104659-21-021553

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001104659-21-021553

Filing Date

2021-02-12

Accepted

2021-02-12 12:05:17

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	tm211883-6_424b3.htm	424B3	7065449
2	GRAPHIC	lg_anchiano-4c.jpg	GRAPHIC	33160
3	GRAPHIC	sg_stanislavpolo-bw.jpg	GRAPHIC	21348
4	GRAPHIC	tm211883d1-bc_pipeline4clr.jpg	GRAPHIC	99438
5	GRAPHIC	tm211883d1-fc_role4clr.jpg	GRAPHIC	127065
6	GRAPHIC	tm211883d1-tbl_target4clr.jpg	GRAPHIC	167711
7	GRAPHIC	tm211883d1-tbl_solution4clr.jpg	GRAPHIC	140755
8	GRAPHIC	tm211883d1-pht_levels4clr.jpg	GRAPHIC	117284
9	GRAPHIC	tm211883d1-pht_biopsies4clr.jpg	GRAPHIC	73111
10	GRAPHIC	tm211883d1-lc_patient4cbw.jpg	GRAPHIC	73368
11	GRAPHIC	tm211883d1-bc_circulat4clr.jpg	GRAPHIC	42262
12	GRAPHIC	tm211883d1-pht_tissue4clr.jpg	GRAPHIC	142046
13	GRAPHIC	tm211883d1-pht_skintise4clr.jpg	GRAPHIC	138896
14	GRAPHIC	tm211883d1-lc_fibrotic4cbw.jpg	GRAPHIC	32349
15	GRAPHIC	tm211883d1-bc_fiveadmin4clr.jpg	GRAPHIC	44167
16	GRAPHIC	tm211883d1-bc_nineadmin4clr.jpg	GRAPHIC	55267
17	GRAPHIC	tm211883d1-bc_eightadmn4clr.jpg	GRAPHIC	49317
18	GRAPHIC	tm211883d1-lc_activaton4cbw.jpg	GRAPHIC	23761
19	GRAPHIC	tm211883d1-pht_fibrosis4clr.jpg	GRAPHIC	79690
20	GRAPHIC	tm211883d1-bc_monocytes4cbw.jpg	GRAPHIC	41247
21	GRAPHIC	tm211883d1-pht_healthy4clr.jpg	GRAPHIC	107032
22	GRAPHIC	tm211883d1-pht_dermal4clr.jpg	GRAPHIC	129275
23	GRAPHIC	tm211883d1-pht_inhibits4clr.jpg	GRAPHIC	172789
24	GRAPHIC	lg_oppenheimer.jpg	GRAPHIC	15604
25	GRAPHIC	sg_oppenheimer-lr.jpg	GRAPHIC	15343
	Complete submission text file	0001104659-21-021553.txt		9738786

Mailing Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401

Business Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401 972-2-5486555

Anchiano Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)